NCT02162446View on ClinicalTrials.gov

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Gastroenteropancreatic Neuroendocrine Tumors

Interventions

DRUG

satoreotide trizoxetan

Trial Locations (1)

CH-4031

University Hospital Basel, Basel

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Ipsen

INDUSTRY